Cancer (Oncology)

Glenza 160® Enzalutamide Tablets
Enzalutamide 160mg
- Composition
- Enzalutamide 160mg
- Dosage form
- Tablet
- Pack size
- Strip of 7 Tablet
- Manufacturer
- Glenmark Pharmaceuticals
- Also known as
- Xtandi
Supplied against a valid prescription where required, in line with the regulations of the destination country.
Glenza 160 mg contains enzalutamide, a hormonal anticancer medicine used to treat several forms of prostate cancer, including metastatic hormone-sensitive and castration-resistant disease. It works by blocking androgen receptor signalling, reducing the effects of male hormones that can promote prostate cancer growth
As prescribed by a doctor. Dose and duration depend on the condition being treated and the patient. Do not change the dose without medical advice.
Side effects vary by patient. Common and serious side effects are listed in the pack insert. Contact a doctor if you have severe or unexpected symptoms.
Tell your doctor about other medicines you take, allergies, pregnancy or breastfeeding, and any liver or kidney conditions before use.
Store below 30 °C in a dry place, in the original pack, out of reach of children.
Need product documents?
Ask for the pack insert, batch details or a COA with your quote.
Ask on WhatsApp →Related products
Cancer (Oncology)
Cancer (Oncology)
Cancer (Oncology)
Cancer (Oncology)
